| 000 | 01445 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513040751.0 | ||
| 264 | 0 | _c19950503 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrannini, E | |
| 245 | 0 | 0 |
_aInsulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c1994 |
||
| 300 |
_aS61-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAging _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aHypokalemia _xchemically induced |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 700 | 1 | _aSeghieri, G | |
| 700 | 1 | _aMuscelli, E | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 24 Suppl 3 _gp. S61-9 |
|
| 999 |
_c7699479 _d7699479 |
||